Care Access - Houston

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Obesity3 trials
• Alzheimer disease2 trials
• Fatty liver disease (MASLD/MASH)1 trial
• Osteoarthritis1 trial
• Type 2 diabetes1 trial

Phase

• Phase 36 trials

Status

• Active, not recruiting3 trials
• Recruiting3 trials

Lead sponsor

• Eli Lilly and Company6 trials

Running trials

• Recruiting

  Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

  NCT07353931· Phase 3· Eli Lilly and Company· Source

  Contact: Akpobome Wodi (principal investigator)

• Active, not recruiting

  A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight

  NCT07232719· Phase 3· Eli Lilly and Company· Source

• Recruiting

  A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  NCT07165028· Phase 3· Eli Lilly and Company· Source

  Contact: Ali Bajwa (principal investigator)

• Recruiting

  Epidemiology and Biomarker Study in Alzheimer's Disease

  NCT07142954· Phase 3· Eli Lilly and Company· Source

  Contact: Ali Bajwa (principal investigator)

• Active, not recruiting

  A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity

  NCT06859268· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)

  NCT06653153· Phase 3· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Obesity1 recruiting
• Osteoarthritis1 recruiting